Log In
Print
BCIQ
Print
Print this Print this
 

Acetadote, acetylcysteine

  Manage Alerts
Collapse Summary General Information
Company Cumberland Pharmaceuticals Inc.
DescriptionIntravenous acetylcysteine
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPoisoning
Indication DetailsTreat acetaminophen poisoning; Treat non-acetaminophen induced acute liver failure
Regulatory Designation

Partner

Harbin Gloria Pharmaceuticals Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today